WHO panel advises on governance of genome editing
Interviewee/Contributor
Victoria English
Organisation
MedNous
Research Directory
VectorY Therapeutics targets misfolded proteins
Interviewee/ContributorAlexander Vos and Sander van DeventerOrganisationVectorY Therapeutics BVHow faster insulin can enable the artificial pancreas
Interviewee/ContributorDavid GerringOrganisationArecor Therapeutics PlcRevisiting herpes simplex virus leads to invention
Interviewee/ContributorGerald KleymannOrganisationInnovative Molecules GmbHShining a light on the dark genome
Interviewee/ContributorDanuta JeziorskaThe next direction for Alzheimer's disease treatments
Interviewee/ContributorJean-Claude MullerOrganisationMedNousA new start for an amyloidosis therapy
Interviewee/ContributorPierre VandepapelièreOrganisationAmyl Therapeutics BVThe RECOVERY trial - what has been achieved so far?
Interviewee/ContributorPeter CharlishOrganisationMedNousStock market performance: Tobacco reinvents itself
Interviewee/ContributorVictoria EnglishOrganisationMedNousA new paradigm for gene therapy
Interviewee/ContributorPeter MarksOrganisationUS Food and Drug Administration